Publication at Second Faculty of Medicine |
2008
Abstract
The growing incidence and prevalence of type 2 diabetes mellitus raise concerns about the development of a pandemic. In developed countries, it affects four percent to seven percent of the population.
It leads to the development of vascular complications - microvascular and macrovascular - and thus worsens the length and quality of life of its carriers. In particular, the morbidity and mortality from cardiovascular disease resulting from diabetes-accelerated atherosclerosis is alarming.
The treatment of diabetes mellitus is therefore comprehensive and includes not only the treatment of hyperglycemia but also hypertension, dyslipidemia, microalbuminuria and acetylsalicylic acid treatment.